
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Balance Sheet: Strong Balance Sheet.
Growth: Awesome revenue growth! Revenue grew 20.2% over last year and 74% in last three years on TTM basis.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Size: Market Cap wise it is among the top 20% companies of india.
Technicals: Bullish SharesGuru indicator.
Profitability: Very strong Profitability. One year profit margin are 17%.
Momentum: Stock price has a strong positive momentum. Stock is up 13.2% in last 30 days.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: Outperforming stock! In past three years, the stock has provided 127.3% return compared to 7.9% by NIFTY 50.
No major cons observed.
Valuation | |
|---|---|
| Market Cap | 14.55 kCr |
| Price/Earnings (Trailing) | 82.2 |
| Price/Sales (Trailing) | 14.11 |
| EV/EBITDA | 48.9 |
| Price/Free Cashflow | 307.92 |
| MarketCap/EBT | 62.3 |
| Enterprise Value | 14.7 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 1.03 kCr |
| Rev. Growth (Yr) | 12.9% |
| Earnings (TTM) | 176.8 Cr |
| Earnings Growth (Yr) | 16.7% |
Profitability | |
|---|---|
| Operating Margin | 22% |
| EBT Margin | 22% |
| Return on Equity | 23.71% |
| Return on Assets | 14.82% |
| Free Cashflow Yield | 0.32% |
Growth & Returns | |
|---|---|
| Price Change 1W | 3.3% |
| Price Change 1M | 13.2% |
| Price Change 6M | 57.3% |
| Price Change 1Y | 99.5% |
| 3Y Cumulative Return | 127.3% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -184.72 Cr |
| Cash Flow from Operations (TTM) | 225.72 Cr |
| Cash Flow from Financing (TTM) | -39.29 Cr |
| Cash & Equivalents | 20.79 Cr |
| Free Cash Flow (TTM) | 47.24 Cr |
| Free Cash Flow/Share (TTM) | 10.28 |
Balance Sheet | |
|---|---|
| Total Assets | 1.15 kCr |
| Total Liabilities | 430.06 Cr |
| Shareholder Equity | 716.67 Cr |
| Current Assets | 450.14 Cr |
| Current Liabilities | 361.2 Cr |
| Net PPE | 577.33 Cr |
| Inventory | 150.78 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.15 |
| Debt/Equity | 0.24 |
| Interest Coverage | 13.03 |
| Interest/Cashflow Ops | 15.22 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 2 |
| Dividend Yield | 0.09% |
| Shares Dilution (1Y) | 0.10% |
| Shares Dilution (3Y) | 0.30% |
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Balance Sheet: Strong Balance Sheet.
Growth: Awesome revenue growth! Revenue grew 20.2% over last year and 74% in last three years on TTM basis.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Size: Market Cap wise it is among the top 20% companies of india.
Technicals: Bullish SharesGuru indicator.
Profitability: Very strong Profitability. One year profit margin are 17%.
Momentum: Stock price has a strong positive momentum. Stock is up 13.2% in last 30 days.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: Outperforming stock! In past three years, the stock has provided 127.3% return compared to 7.9% by NIFTY 50.
No major cons observed.
Investor Care | |
|---|---|
| Dividend Yield | 0.09% |
| Dividend/Share (TTM) | 2 |
| Shares Dilution (1Y) | 0.10% |
| Earnings/Share (TTM) | 38.47 |
Financial Health | |
|---|---|
| Current Ratio | 1.25 |
| Debt/Equity | 0.24 |
Technical Indicators | |
|---|---|
| RSI (14d) | 69.18 |
| RSI (5d) | 59.71 |
| RSI (21d) | 70.61 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Sell |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Sell |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Buy |
| SMA 20 Signal | Buy |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
Summary of Shaily Engineering Plastics's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In the Q4 FY '26 earnings call, management provided an optimistic outlook for Shaily Engineering Plastics Limited, highlighting the momentum in key segments despite challenges in the global operating environment.
Key Forward-Looking Points from Management:
Healthcare Segment Growth: The Healthcare segment saw revenue double in Q4 FY '26, with full-year revenue soaring 139% to INR 393 crores, now contributing 40% to consolidated revenue, up from 21% the previous year. Management expects to sustain this growth trajectory and confirmed commercial supply agreements, particularly for Semaglutide injectors.
Consumer Electronics and Semiconductor Opportunities: The company has commenced commercial supplies to a consumer electronics customer and signed a supply agreement for semiconductor trays with a Korean company, marking significant new growth avenues. Management anticipates these two segments will be substantial contributors to future revenue.
Capacity Expansion: Shaily plans to raise up to INR 500 crores annually to ensure capital availability for growth opportunities. The company aims to optimize its pen injector capacity, projecting a total of 40 million to 42 million pens by the end of the year, striving towards 36 million pens in FY '27.
Segment Performance: The industrial revenue grew 41% for FY '26, while the consumer segment faced a decline of 9% due to weaker market demand. Management aims to restore growth momentum in the consumer home furnishing segment while diversifying through consumer electronics and semiconductors.
Operational Improvements: Machine utilization improved to 47.6% in FY '26 from 42.2% the previous year. EBITDA for Q4 FY '26 was INR 69 crores, a 27% growth year-on-year, indicating a healthier operational efficiency.
Future Focus: The strategic priorities for FY '27 include scaling the healthcare vertical, building the Abu Dhabi facility as planned, ramping up consumer electronics, and restoring momentum in the consumer sector.
Overall, management is focused on leveraging its existing capabilities to ensure continued growth and adaptation to market dynamics.
Q1: Are your customers asking for more products given the successful launch of Semaglutide in Canada?
Yes. In Canada, we've received requests for additional product supply, and we're preparing to enhance our production capacity as quickly as possible to meet this demand.
Q2: What capacity do we currently have for Semaglutide, and how much of that is being utilized?
The 25 million capacity installed in March operates at about 45% efficiency. We have a mixed capacity from the previous 30 million, only a small portion dedicated to Semaglutide.
Q3: What is the target capacity for both production lines by year-end?
By year-end, we aim for both production lines to reach an optimal utilization of 65 to 67 parts per minute, providing a combined capacity of approximately 40 to 42 million pens.
Q4: How will the semiconductor and consumer electronics opportunities affect margin profiles?
Margins may remain under pressure initially as scale increases. Historically, we see margins improve significantly post achieving certain production volumes in complex manufacturing like consumer electronics.
Q5: What volume are you targeting for pen injectors in FY27?
We project targeting around 36 million pen injectors for FY27, considering ramp-up and new capacity installations.
Q6: What is the capacity ramp-up plan for FY28?
By FY28, we expect to achieve a capacity of around 35 to 40 million pens, pending successful ramp-up and efficiency improvements.
Q7: What percentage of filings in Canada and Brazil are associated with Shaily devices?
In Canada, we estimate that 70% of the top six filers are our clients. In Brazil, it's complex due to partnership arrangements, but we anticipate being involved in the first approvals.
Q8: What has been the initial feedback from customers after the launch?
We've received minor complaints, primarily user-related. Overall, performance feedback has been positive, especially regarding customer trust in the product.
Q9: What was the purpose behind the recent INR 500 crores fundraise resolution?
The resolution allows us to seize time-sensitive, capital-intensive opportunities as they arise, ensuring we remain agile in expanding capacities.
Q10: How do you see the future of the semiconductor market opportunities in India?
We anticipate substantial demand, particularly as more semiconductor fabs establish operations here. We believe our technical competence will be a competitive advantage against global players.
Understand Shaily Engineering Plastics ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| TILOTTAMA SANGHVI | 14% |
| JAYESSH MOHANLAL SHAH | 8.29% |
| SMALLCAP WORLD FUND, INC | 7.8% |
| MAHENDRA BHOGILAL SANGHVI | 7.24% |
| MOTILAL OSWAL SPECIAL OPPORTUNITIES FUND | 5.38% |
| LAXMAN SANGHVI | 5.07% |
| BANDHAN SMALL CAP FUND | 3.47% |
| ASHISH KACHOLIA | 3.22% |
| SHAILY MAHENDRA SANGHVI | 2.83% |
| AMIT MAHENDRA SANGHVI | 2.62% |
| SURYAVANSHI COMMOTRADE PRIVATE LIMITED | 1.99% |
| BOFA SECURITIES EUROPE SA - ODI | 1.69% |
| ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE SMALL CAP FUND | 1.14% |
| KALPANA LAXMAN SANGHVI | 0.82% |
| RAMESH H SHAH | 0.12% |
| PURNIMA MOHANLAL SHAH | 0.11% |
| LAX NAGDA | 0% |
| LATE BHARAT BHOGILAL SANGHVI | 0% |
| RAJEN BHARAT SANGHVI | 0% |
| RASHMI SANGHVI | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Shaily Engineering Plastics against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| SUPREMEIND | Supreme Industries | 43.72 kCr | 11.36 kCr | +8.30% | -17.60% | 42.14 | 3.85 | - | - |
| TIMETECHNO | Time Technoplast | 10.11 kCr | 6.45 kCr | +17.60% | -9.00% | 19.87 | 1.57 | - | - |
| POLYPLEX | Polyplex Corp | 3.5 kCr | 7.23 kCr | +9.50% | -1.80% | 77.93 | 0.48 | - | - |
| PLASTIBLEN | Plastiblends India | 513.78 Cr | 823.52 Cr | +16.20% | +4.00% | 12.03 | 0.62 | - | - |
Comprehensive comparison against sector averages
SHAILY metrics compared to Industrial
| Category | SHAILY | Industrial |
|---|---|---|
| PE | 85.54 | 40.98 |
| PS | 14.55 | 3.09 |
| Growth | 26.6 % | 7.4 % |
Shaily Engineering Plastics Limited engages in the manufacture and sale of precision injection moulded plastic components/products in India. The company offers specialty devices, platform devices, inhalers, sprays and pumps, intricate insulin injector pens, auto injectors, and specialty packaging and containers for solid and liquid formulations, as well as provides contract development and manufacturing services for pharmaceutical industry. It also offers kitchen and cooking devices, and storage and cleaning products; plastic and plastic/electronic toys; and sheet steel furniture products, including cabinets, drawer units, tables, and storage units. In addition, the company provides plastic components for lighting, appliances, and automotive applications; and razors and stylish casing for cosmetics. It also exports its products to approximately 40 countries. The company was incorporated in 1980 and is based in Vadodara, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
SHAILY vs Industrial (2023 - 2026)